Aortic valve leaflet disruption techniques in transcatheter aortic valve replacement

With continued technological advancement and technical improvement of transcatheter aortic valve replacement (TAVR), it has become a desirable treatment option for aortic valve stenosis. Its minimally invasive approach compared to surgical aortic valve replacement offers the treatment to a broader patient population, mainly non-surgical candidates. A feared complication of TAVR is the occlusion of coronary artery ostium by the native aortic valve leaflet due to its displacement by the expanded transcatheter valve. Bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction (BASILICA) is a technique developed to mitigate this risk by creating a lengthwise laceration of the left and/or right aortic valve leaflets prior to TAVR. Patient outcomes following TAVR with BASILICA have been promising. Meticulous preoperative examination, patient selection, and hemodynamic management are imperative. With continued refinement, BASILICA may further expand the application of TAVR to patients at high risk for coronary occlusion associated with the procedure.

Since the very first human transcatheter aortic valve replacement (TAVR) procedure in 2002, more than 200,000 TAVRs have been performed worldwide.^[1] Though it was reserved for select non-surgical candidates in the early stages of development, its application is expanding considerably in recent years. Large randomized controlled studies have compared outcomes of TAVR versus surgical aortic valve replacement (SAVR) for intermediate and high-risk patients and found no significant difference in primary outcome of morbidity from major stroke or mortality at one year and two years, respectively.^[2,3] Furthermore, a study of similar design involving low-risk patients found that TAVR patients had significantly lower rate of death, stroke, or rehospitalization at one year.^[4] Another evolving application of TAVR is to salvage a failing bioprosthetic valve, known as valve-in-valve (ViV) procedure.^[5] Minimally invasive aspect of TAVR confers a major advantage over SAVR, and the patient outcomes have been promising thus far. Despite its advantages, TAVR is associated with several notable risks. Firstly, without follow-up data from past six years, the durability of TAVR valves is uncertain. Therefore, current recommendations still favor SAVR for younger patients with longer life expectancy.^[6,7] However, one of the most consequential intraoperative complications of TAVR is the occlusion of coronary artery. With the placement of the prosthetic valve, an existing aortic valve leaflet may displace outward and directly occlude the adjacent coronary ostium or block the entire sinus of Valsalva, resulting clinically significant coronary obstruction. The left coronary ostium is much more frequently affected than the right coronary ostium, likely due to its lower height of the ostium in relation to the leaflet.^[8] Most cases of coronary obstruction manifest as severe hypotension immediately following the deployment of the prosthetic valve.^[8–10] The incidence is less than 1% in TAVR performed on native aortic valves, but it increases over 3-fold in ViV TAVR procedures.^[11,12] Majority of patients with TAVR-related coronary obstruction in the past have received emergent percutaneous coronary intervention and a much smaller number received coronary artery bypass grafting.^[8] Despite these measures, the 30-day mortality of coronary obstruction in patients undergoing ViV TAVR is reported to be 48.6%, which is likely much higher than in patients with coronary obstruction during native valve TAVR.^[8,11]Given the high rate of catastrophic outcomes associated with coronary obstruction, efforts must be devoted to preventive strategies. Several factors have been identified which include pre-existing surgical bioprosthetic aortic valve, older age, female gender, no history of coronary artery bypass grafting, and higher risk profile according to the logistic European System for Cardiac Operative Risk Evaluation (logEuroSCORE).^[10] The patient characteristics are likely significant due to the anatomic variability associated with them which include significantly smaller aortic annulus areas, sinus of Valsalva diameters, sino-tubular junction diameters, and lower left coronary artery heights as.^[10] In ViV patients, the prior surgical valve location, manipulation of the aortic root, and implantation of coronary grafts may affect these parameters considerably.^[12] With knowledge of these factors contributing to the risk of coronary obstruction, meticulous protocols are applied to stratify patient risk, as well as to plan the procedure appropriately.^[13,14]Bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction (BASILICA) is a novel technique developed to create a lengthwise laceration down the middle of an aortic valve leaflet from the base to the tip.^[15] The goal of this technique is to prevent coronary obstruction by creating a separation in the existing valve leaflet through which the coronary artery can remain open and perfused when the leaflet is displaced outward by the transcatheter valve and the details have been previously described.^[14,15] Briefly, this is accomplished by traversing an electrified guidewire through the mid-base of the valve leaflet of interest. The guidewire is then captured by a ring snare pre-positioned at the aortic outflow tract through a separate catheter. Then the guidewire and snare are both manipulated to position the cutting segment of the electrified guidewire in contact with the valve leaflet, which creates the valve laceration with electrocautery (Figure 1).Open in a separate windowFigure 1Schematic illustration (A) and transesophageal echocardiography (B) of mid-esophageal long axis view showing the electrocautery apparatus (arrow) in place for BASILICA.BASILICA: bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction.Initial testing of BASILICA in swine revealed successful laceration of the aortic valve leaflet without collateral injury on necropsy, except in the first trial while refining the technique.^[15] Clinical trial was subsequently performed and showed promising results.^[16] Of 30 patients, all subjects were free of coronary obstruction, despite being categorized as high risk based on preoperative evaluation.^[16] Due to the relatively small sample size, several questions remained unanswered regarding the safety of BASILICA, such as the risk of stroke and major vascular complications. However, many centers began to perform BASICILA over the recent years, including here at UC Davis Medical Center. As a result, the multicenter international BASILICA registry has accumulated data on 214 patients who underwent the procedure at 25 centers in North America and Europe.^[17] Analysis of the registry revealed that leaflet laceration was performed successfully in 94.4% of the patients and among those patients, 4.7% of patients experienced partial or complete coronary occlusion.^[17] The patients with coronary obstruction were successfully treated with coronary stents, but one patient died from cardiogenic shock despite the interventions. Considering the previously established mortality ranging between 40% and 50% in patients who experience coronary obstruction due to TAVR without BASILICA, the mortality of 10% in patients who experience coronary obstruction with BASILICA bolsters the benefits of this procedure.^[18] The authors’ explanation for this finding is that the obstruction resulting after BASILICA is not flow-limiting and the space created by BASILICA often allows placement of coronary stents through the struts of the transcatheter valve, instead of the traditional “snorkel” stent.^[17] Overall, the 30-day mortality and incidence of stroke reported through this registry were 2.8% and 2.8%, respectively.^[18] This is similar to the data of all patients undergoing TAVR reported by the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.^[18] Considering that patients who underwent BASILICA are at higher risk than the average TAVR patients, this result supports the implementation of BASILICA for this subset of patients.BASILICA requires meticulous planning and certain patient factors make the procedure less feasible. A large portion of the failed BASILICA were attributed to failure to traverse the electrified guidewire through the leaflet due to the extensive calcification. Hence, it may be a relative contraindication for the procedure. Anesthetic planning is also an important component in taking care of these hemodynamically fragile TAVR patients. This is highlighted by the authors of the BASILICA registry analysis, who attributed one of the deaths to cardiogenic shock resulting from the anesthesia induction.^[18] Although moderate sedation may be considered, there is a strong preference for general anesthesia (GA) with endotracheal intubation. In case of severe hemodynamic compromise that requires emergent surgical intervention or mechanical circulatory support, GA with a secure airway is necessary. Furthermore, transesophageal echocardiogram (TEE) can be performed much more safely with a secured airway with an endotracheal tube. Particularly in this patient population, critical intraoperative complications, such as wall motion abnormalities can be detected early using TEE to direct clinical management.